A Risk-Adapted Protocol of Prophylactic Zoledronic Acid Prevents Bone Mineral Density Loss Post Allograft: Results of the ALLG Bm07 Phase II Prospective Trial

Eric Wong; Belinda Butcher; Bereha Khodr; Ashish Bajel; Mark Hertzberg; Sushrut Patil; Alwyn D'Souza; Peter Ganley; Peter Ebeling; Andrew Grigg

doi:10.1016/j.bbmt.2017.01.065

A Risk-Adapted Protocol of Prophylactic Zoledronic Acid Prevents Bone Mineral Density Loss Post Allograft: Results of the ALLG Bm07 Phase II Prospective Trial

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2017.01.065 ◽

2017 ◽

Vol 23 (3) ◽

pp. S68-S69

Author(s):

Eric Wong ◽

Belinda Butcher ◽

Bereha Khodr ◽

Ashish Bajel ◽

Mark Hertzberg ◽

...

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Bone Mineral ◽

Phase Ii ◽

Prospective Trial ◽

Mineral Density ◽

Bone Mineral Density Loss

Download Full-text

Randomized phase II trial evaluating different schedules of zoledronic acid administration on bone mineral density in patients with stage D prostate cancer beginning androgen deprivation.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4643 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4643-4643 ◽

Cited By ~ 1

Author(s):

J. M. Lang ◽

J. C. Eickhoff ◽

N. C. Binkley ◽

M. J. Staab ◽

G. Liu ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Bone Mineral ◽

Phase Ii ◽

Phase Ii Trial ◽

Mineral Density ◽

Randomized Phase Ii ◽

Acid Administration ◽

Stage D

Download Full-text

Effect of Zoledronic Acid on Reducing Femoral Bone Mineral Density Loss following Total Hip Arthroplasty

The Journal of Arthroplasty ◽

10.1016/j.arth.2012.08.007 ◽

2013 ◽

Vol 28 (4) ◽

pp. 671-675 ◽

Cited By ~ 21

Author(s):

David F. Scott ◽

Jennifer N. Woltz ◽

Rachel R. Smith

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Total Hip Arthroplasty ◽

Bone Mineral ◽

Hip Arthroplasty ◽

Femoral Bone ◽

Mineral Density ◽

Femoral Bone Mineral Density ◽

Bone Mineral Density Loss ◽

Total Hip

Download Full-text

A Randomized Phase II Trial Evaluating Different Schedules of Zoledronic Acid on Bone Mineral Density in Patients With Prostate Cancer Beginning Androgen Deprivation Therapy

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2013.04.029 ◽

2013 ◽

Vol 11 (4) ◽

pp. 407-415 ◽

Cited By ~ 9

Author(s):

Joshua M. Lang ◽

Marianne Wallace ◽

Jordan T. Becker ◽

Jens C. Eickhoff ◽

Bjoern Buehring ◽

...

Keyword(s):

Prostate Cancer ◽

Bone Mineral Density ◽

Zoledronic Acid ◽

Androgen Deprivation Therapy ◽

Bone Mineral ◽

Phase Ii ◽

Phase Ii Trial ◽

Androgen Deprivation ◽

Mineral Density ◽

Randomized Phase Ii

Download Full-text

Zoledronic Acid Prevents Bone Mineral Density Loss at the Hip, but not at the Knee, in Persons with Acute Spinal Cord Injury

Journal of Clinical Densitometry ◽

10.1016/j.jocd.2013.05.025 ◽

2013 ◽

Vol 16 (3) ◽

pp. 269

Author(s):

Christopher Cirnigliaro ◽

Michael LaFountaine ◽

Steven Kirshblum ◽

Leighann Martinez ◽

Pierre Asselin ◽

...

Keyword(s):

Bone Mineral Density ◽

Spinal Cord ◽

Spinal Cord Injury ◽

Zoledronic Acid ◽

Bone Mineral ◽

Acute Spinal Cord Injury ◽

Mineral Density ◽

Bone Mineral Density Loss ◽

Cord Injury

Download Full-text

Review for "Differing effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy: a randomised controlled trial"

10.1002/jbmr.4106/v2/review2 ◽

2020 ◽

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Randomised Controlled Trial ◽

Androgen Deprivation Therapy ◽

Bone Mineral ◽

Bone Microarchitecture ◽

Controlled Trial ◽

Androgen Deprivation ◽

Mineral Density ◽

Randomised Controlled

Download Full-text

Review for "Differing effects of zoledronic acid on bone microarchitecture and bone mineral density in men receiving androgen deprivation therapy: a randomised controlled trial"

10.1002/jbmr.4106/v1/review1 ◽

2020 ◽

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Randomised Controlled Trial ◽

Androgen Deprivation Therapy ◽

Bone Mineral ◽

Bone Microarchitecture ◽

Controlled Trial ◽

Androgen Deprivation ◽

Mineral Density ◽

Randomised Controlled

Download Full-text

Genetic determinants of bone mineral density loss in aromatase inhibitors treatment in the B-ABLE Cohort

Bone Abstracts ◽

10.1530/boneabs.3.pp192 ◽

2014 ◽

Author(s):

Maria Rodriguez-Sanz ◽

Natalia Garcia-Giralt ◽

Pliego Elisa Torres-del ◽

Daniel Prieto-Alhambra ◽

Sonia Servitja ◽

...

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Aromatase Inhibitors ◽

Genetic Determinants ◽

Mineral Density ◽

Bone Mineral Density Loss

Download Full-text

Fracture and bone mineral density outcomes after bisphosphonate discontinuation in children with osteogenesis imperfecta treated with zoledronic acid compared to pamidronate

Bone Abstracts ◽

10.1530/boneabs.4.p39 ◽

2015 ◽

Author(s):

Ryan Heksch ◽

Sasigarn Bowden ◽

Scott Hickey ◽

John Mahan

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Osteogenesis Imperfecta ◽

Bone Mineral ◽

Mineral Density

Download Full-text

Faculty Opinions recommendation of Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.13377017.14747132 ◽

2011 ◽

Author(s):

James Triffitt ◽

Xuchen Duan

Keyword(s):

Bone Mineral Density ◽

Zoledronic Acid ◽

Bone Turnover ◽

Bone Mineral ◽

Secondary Osteoporosis ◽

Mineral Density

Download Full-text

Faculty Opinions recommendation of Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.2457956.2095054 ◽

2010 ◽

Author(s):

Alexander Ford

Keyword(s):

Bone Mineral Density ◽

Proton Pump Inhibitor ◽

Bone Mineral ◽

Proton Pump ◽

Mineral Density ◽

Bone Mineral Density Loss

Download Full-text